ADA and colitis: Adenosine deaminase inhibition alleviates the elevation of colonic myeloperoxidase and malondialdehyde levels in rats with colitis, demonstrating that adenosine can modulate the immune system and suppress inflammation by reducing pro-inflammatory cytokine biosynthesis and regulating neutrophil function (55).